Details for New Drug Application (NDA): 204806
✉ Email this page to a colleague
The generic ingredient in ATAZANAVIR SULFATE is atazanavir sulfate. There are twenty-five drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the atazanavir sulfate profile page.
Summary for 204806
Tradename: | ATAZANAVIR SULFATE |
Applicant: | Aurobindo Pharma |
Ingredient: | atazanavir sulfate |
Patents: | 0 |
Suppliers and Packaging for NDA: 204806
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 204806 | ANDA | Aurobindo Pharma Limited | 65862-710 | 65862-710-03 | 3 BLISTER PACK in 1 CARTON (65862-710-03) / 10 CAPSULE in 1 BLISTER PACK (65862-710-10) |
ATAZANAVIR SULFATE | atazanavir sulfate | CAPSULE;ORAL | 204806 | ANDA | Aurobindo Pharma Limited | 65862-710 | 65862-710-05 | 500 CAPSULE in 1 BOTTLE (65862-710-05) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 100MG BASE | ||||
Approval Date: | Jun 25, 2018 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 150MG BASE | ||||
Approval Date: | Jun 25, 2018 | TE: | AB | RLD: | No |
Profile for product number 003
Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | EQ 200MG BASE | ||||
Approval Date: | Jun 25, 2018 | TE: | AB | RLD: | No |
Complete Access Available with Subscription